loading

Greenwich Lifesciences Inc Azioni (GLSI) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
23.26%
4.046
3.2823 8.0842 2.7291 2.6614
Operating Income/Loss
23.26%
-4.046
-3.2823 -8.0842 -2.7291 -2.6614
Income/Loss From Continuing Operations Before Tax
23.54%
-4.0253
-3.2584 -8.0402 -2.6687 -2.6067
Income/Loss From Continuing Operations After Tax
23.54%
-4.0253
-3.2584 -8.0402 -2.6687 -2.6067
Net Income/Loss
23.54%
-4.0253
-3.2584 -8.0402 -2.6687 -2.6067
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1.51%
13.37
13.17 0.0445 13.14 12.91
Diluted Average Shares
1.51%
13.37
13.17 0.0445 13.14 12.91
Basic Earnings Per Share
20.00%
-0.30
-0.25 -0.61 -0.20 -0.20
Diluted Earnings Per Share
20.00%
-0.30
-0.25 -0.61 -0.20 -0.20
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$37.76
price up icon 1.09%
$28.91
price up icon 0.72%
$102.30
price up icon 0.64%
$104.01
price up icon 0.05%
biotechnology ONC
$310.20
price down icon 0.46%
$183.65
price down icon 1.35%
Capitalizzazione:     |  Volume (24 ore):